Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
---|
06/22/1993 | CA1319364C Fused heterocyclic compounds |
06/22/1993 | CA1319324C Therapeutical compositions against psoriasis |
06/22/1993 | CA1319321C Pharmaceutical preparations |
06/19/1993 | CA2085456A1 17beta-n-substituted adamantyl/norbornanyl carbamoyl-4-aza-5a -androst -1-en-3-ones and adrostan-3-ones as 5a-reductase inhibitors |
06/18/1993 | WO1993012072A1 Process for preparing optically active cyanohydrins with enzymes |
06/17/1993 | DE4141746A1 20-methyl-substituierte vitamin d-derivate 20-methyl-substituted vitamin d derivatives |
06/16/1993 | EP0545946A1 Growth-promoting agent |
06/16/1993 | EP0308500B1 Human somatomedin carrier protein subunits and process for producing them |
06/16/1993 | EP0290558B1 Antifolate agents |
06/16/1993 | CN1073094A Pharmaceutical composition containing felbinac |
06/15/1993 | US5219749 Process for isolating and preparing purified chitin deacetylase |
06/15/1993 | CA1319149C Pharmacologically active 2-and 3-substituted (1',5'-diaryl-3-pyrazolyl)-n-hydroxypropanamides and method for synthesizing the same |
06/15/1993 | CA1319121C Cysteine proteinases, production and use |
06/15/1993 | CA1319111C Anti-acne composition |
06/10/1993 | WO1993011105A1 Leukotriene-b4 derivatives, process for preparing the same and medicaments |
06/10/1993 | WO1993010811A1 Proteolytic mixture containing escharase and method of isolating same |
06/10/1993 | WO1993010808A1 INHIBITING TRANSFORMING GROWTH FACTOR β TO PREVENT ACCUMULATION OF EXTRACELLULAR MATRIX |
06/10/1993 | WO1993010802A1 Aqueous synthetic organ extracts |
06/10/1993 | WO1993010791A1 Use of a known chemical compound for the production of a pharmaceutical composition for topical application |
06/10/1993 | WO1993010776A1 Wound healing compositions containing a pyruvate, an antioxidant and a mixture of fatty acids |
06/10/1993 | WO1993010756A1 Use of salicylic acid for regulating skin wrinkles and/or skin atrophy |
06/10/1993 | WO1993010755A1 Compositions for regulating skin wrinkles and/or skin atrophy |
06/10/1993 | WO1993010754A1 Skin care composition |
06/10/1993 | WO1993010741A2 Sex steroid activity inhibitors |
06/10/1993 | CA2124944A1 Skin care composition |
06/10/1993 | CA2124852A1 Use of a known chemical compound for the production of a pharmaceutical composition for topical application |
06/10/1993 | CA2124591A1 Inhibiting transforming growth factor .beta. to prevent accumulation of extracellular matrix |
06/10/1993 | CA2123678A1 Wound healing compositions containing a pyruvate, an antioxidant and a mixture of fatty acids |
06/10/1993 | CA2122992A1 Leukotriene-b derivatives, process for preparing the same and medicaments |
06/09/1993 | EP0545147A2 Use of radical scavengers and/or substances suitable for deactivating nonradical reactive oxygen species for preventing or delaying human hair greying |
06/09/1993 | CN1072843A Gel-type cosmetic composite |
06/02/1993 | EP0544391A1 Compositions for topical treatment of psoriasis and atopic dermatitis |
06/01/1993 | US5216148 Treating, preventing neoplasms, dermatoses, aging of skin |
05/27/1993 | WO1993010217A1 New cultures of keratinocytes, process for their preparation and their use as wound healing substances |
05/27/1993 | WO1993009812A1 MURINE MONOCLONAL ANTIBODY (5c8) RECOGNIZES A HUMAN GLYCOPROTEIN ON THE SURFACE OF T-LYMPHOCYTES |
05/27/1993 | WO1993009800A1 Inhibitors of cell regulatory factors and methods for preventing or reducing scarring |
05/27/1993 | WO1993009770A1 Bactericidal pharmaceutical composition containing chlorhexidine and eugenol |
05/27/1993 | WO1993009760A2 Dermatological and cosmetic compositions |
05/27/1993 | WO1993006812A3 Use of an emulsion to prepare an intravenously administered medicament for treating skin diseases |
05/27/1993 | CA2378820A1 Murine monoclonal antibody (5c8) recognizes a human glycoprotein on the surface of t-lymphocytes |
05/27/1993 | CA2123910A1 Dermatological and cosmetic compositions |
05/27/1993 | CA2123418A1 Inhibitors of cell regulatory factors and methods for preventing or reducing scarring |
05/26/1993 | EP0543521A2 High dosage topical forms of collagenase |
05/26/1993 | EP0435915B1 Compositions for the treatment of leishmaniasis |
05/26/1993 | CN1020924C Production of pluripotent granule cell colony stimulating factor |
05/26/1993 | CN1020903C (1h-imidazol-1-ylmethyl) substituted benzimidazole derivatives and the preparation therefor |
05/25/1993 | US5213978 Protease from micrococcus sedentarius for degrading protein of human callus or corn tissue |
05/25/1993 | CA1318325C 1-substituted tetralin derivatives, their preparation and their use |
05/19/1993 | EP0542549A1 Use of cosmetic composition |
05/18/1993 | US5212166 Antiandrogens or 5-alpha reductase inhibitors |
05/18/1993 | CA1317973C Tetralin derivatives, their preparation and their use |
05/18/1993 | CA1317964C N-phenyl butenamides with pharmaceutical properties |
05/16/1993 | CA2082693A1 Use of cosmetic compositon |
05/15/1993 | CA2082562A1 The use of preparations of curcuma plants |
05/13/1993 | WO1993009229A1 Recombinant bone morphogenetic protein heterodimers, compositions and methods of use |
05/13/1993 | WO1993008815A1 Pharmaceutical dipeptide compositions and methods of use thereof |
05/13/1993 | WO1993008790A1 Treatment of acne or of pseudofolliculitis barbae |
05/13/1993 | WO1993008687A1 Alteration of rate and character of hair growth |
05/12/1993 | EP0540857A1 Process for preparing stable, complexe emulsion compositions of the water-oil-water type and use of said compositions as cosmetic preparations |
05/12/1993 | EP0540629A1 Use of pyrimidine 3-oxyde derivatives to slow down hair fall and topical compositions implemented. |
05/12/1993 | EP0398945B1 New topical preparation for treatment of alopecia |
05/11/1993 | CA1317547C Anhydrous application form of low molecular alkali huminates |
05/05/1993 | EP0539465A1 Use of 20(r)-22-oxa-vitamin d analogues for the treatment of skin ageing. |
05/05/1993 | EP0289584B1 Wound healing and bone regeneration |
05/04/1993 | US5208035 Water Soluble Polymer Base, Penetration Enhancing Agent |
05/04/1993 | CA1317230C Aqueous preparation of 9-methyl-3-(1h-tetrazol-5-yl)- 4h-pyrido ¬1,2-a|pyrimidin-4-one potassium salt |
04/29/1993 | WO1993008296A1 Oligonucleotides having chiral phosphorus linkages |
04/29/1993 | WO1993007894A1 Dermatomycosis vaccine |
04/29/1993 | WO1993007856A1 LOW pH AQUEOUS COSMETIC GEL CONTAINING NON-IONIC POLYACRYLAMIDE DERIVATIVES |
04/29/1993 | WO1993001165A3 Aromatic compounds, compositions containing them and their use in therapy |
04/28/1993 | EP0539326A2 Bis (phenyl)ethane derivatives |
04/28/1993 | EP0539117A1 Compounds useful as leukotriene antagonists |
04/28/1993 | EP0539087A1 Stabilized topical acidic fibroblast growth factor formulation |
04/28/1993 | EP0538754A2 Use of antibody-containing preparations for immunosuppression |
04/28/1993 | EP0538486A1 Sewing machine needle and method of manufacturing same |
04/28/1993 | EP0538436A1 Novel quaternary ammonium salts, process for obtaining same and pharmaceutical compositions containing them |
04/28/1993 | EP0538384A1 Oxamides |
04/28/1993 | CN1071420A 4-(4-(4-(4-hydroxyphenyl)-1-piperazinyl) phenyl)-5-methyl-3h-1,2,4-triazol-3-one derivatives |
04/28/1993 | CN1071418A Benzo (f) quinolinones |
04/27/1993 | US5206343 Oligopetides with cyclic proline-analogous amino acids |
04/27/1993 | US5206229 Inhibit cell proliferation, antiinflammatory, treating imbalance of immune system |
04/27/1993 | US5206008 Using androstene(diol or triol) |
04/27/1993 | CA1316932C Methods and compositions for inhibiting lipoxygenase |
04/27/1993 | CA1316829C Therapeutic composition containing sucrose fatty acid ester |
04/25/1993 | CA2081133A1 Pharmaceutical compounds |
04/22/1993 | CA2080537A1 Stabilized topical acidic fibroblast growth factor formulation |
04/21/1993 | EP0537429A1 Modified huminates, process for obtaining the same and their uses |
04/21/1993 | EP0537427A1 Process for producing huminates |
04/21/1993 | EP0479871B1 Novel vitamin d analogues |
04/21/1993 | EP0343248B1 Novel polypeptide and method for preparing the same |
04/21/1993 | EP0298121B1 Biocompatible material for treatment of defects in tissues and organs |
04/20/1993 | US5204103 Using vegetable fiber from Plantago ovata with holder for applying to skin; ulcers |
04/20/1993 | CA1316534C Tetrahydronaphthaline and indane derivatives |
04/17/1993 | WO1993008213A1 Novel physiologically active substance epimorphine, gene which codes for same, and antibody against epimorphine |
04/15/1993 | WO1993007262A2 Purified chitin deacetylase |
04/15/1993 | WO1993007137A1 Pyridinol derivatives as medicaments |
04/15/1993 | WO1993007123A1 Fluoroalkylated amphiphilic ligands, their metallic complexes and their uses |
04/15/1993 | WO1993006866A2 Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using inhibitors of the cd2/lfa-3 interaction |
04/15/1993 | WO1993006818A1 Dermatological and/or cosmetological composition containing retinoids |
04/15/1993 | WO1993006812A2 Use of an emulsion to prepare an intravenously administered medicament for treating skin diseases |